T2 Biosystems, Inc. Marketable Securities
T2 Biosystems, Inc. had Marketable Securities of $42.20 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2020-11-05
- 2020-09-30: Marketable Securities $42.20M.
| Period end | Marketable Securities |
|---|---|
| 2020-09-30 | $42.20M 10-Q · filed 2020-11-05 |